Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

In Vivo Multimodal Optical Imaging: Improved Detection of Oral Dysplasia in Low-Risk Oral Mucosal Lesions.

Yang EC, Schwarz RA, Lang AK, Bass N, Badaoui H, Vohra IS, Cherry KD, Williams MD, Gillenwater AM, Vigneswaran N, Richards-Kortum RR.

Cancer Prev Res (Phila). 2018 Aug;11(8):465-476. doi: 10.1158/1940-6207.CAPR-18-0032. Epub 2018 Jun 14.

PMID:
29903741
2.

Securing the Airway in Pretracheal Dermal Metastases From Oropharyngeal Carcinoma: A Case Report.

Truong AT, Truong DT, Gillenwater AM, Soliz JM, Rahlfs TF.

A A Pract. 2018 Oct 15;11(8):221-223. doi: 10.1213/XAA.0000000000000787.

PMID:
29688927
3.

Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions.

Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):670-681. doi: 10.1016/j.oooo.2018.02.020. Epub 2018 Mar 9. Review.

4.

Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay.

Abram TJ, Pickering CR, Lang AK, Bass NE, Raja R, Meena C, Alousi AM, Myers JN, McDevitt JT, Gillenwater AM, Vigneswaran N.

Transl Oncol. 2018 Apr;11(2):477-486. doi: 10.1016/j.tranon.2018.01.014. Epub 2018 Feb 24.

5.

Rare presentation of heterotopic ossification along a fibula free flap pedicle in a high-volume microvascular reconstruction practice.

Mays AC, Gillenwater AM, Garvey PB.

Head Neck. 2018 Mar;40(3):E21-E24. doi: 10.1002/hed.25039. Epub 2017 Dec 22.

PMID:
29272061
6.

Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy.

Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS.

Oral Oncol. 2017 Sep;72:90-97. doi: 10.1016/j.oraloncology.2017.07.002. Epub 2017 Jul 16.

7.

Prospective Evaluation of Multimodal Optical Imaging with Automated Image Analysis to Detect Oral Neoplasia In Vivo.

Quang T, Tran EQ, Schwarz RA, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum R.

Cancer Prev Res (Phila). 2017 Oct;10(10):563-570. doi: 10.1158/1940-6207.CAPR-17-0054. Epub 2017 Aug 1.

8.

Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.

Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN Jr, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS.

Head Neck. 2017 Apr;39(4):633-638. doi: 10.1002/hed.24666. Epub 2016 Dec 22.

PMID:
28006086
9.

Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles.

Lukianova-Hleb EY, Kim YS, Belatsarkouski I, Gillenwater AM, O'Neill BE, Lapotko DO.

Nat Nanotechnol. 2016 Jun;11(6):525-32. doi: 10.1038/nnano.2015.343. Epub 2016 Feb 15.

PMID:
26878142
10.

Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

William WN Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM.

JAMA Oncol. 2016 Feb;2(2):209-16. doi: 10.1001/jamaoncol.2015.4364.

11.

Automated frame selection process for high-resolution microendoscopy.

Ishijima A, Schwarz RA, Shin D, Mondrik S, Vigneswaran N, Gillenwater AM, Anandasabapathy S, Richards-Kortum R.

J Biomed Opt. 2015 Apr;20(4):46014. doi: 10.1117/1.JBO.20.4.046014.

12.

Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy.

Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH.

Head Neck. 2016 Apr;38 Suppl 1:E452-8. doi: 10.1002/hed.24017. Epub 2015 Jul 14.

PMID:
25645649
13.

Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer.

Kawedia JD, Zhang YP, Myers AL, Richards-Kortum RR, Kramer MA, Gillenwater AM, Culotta KS.

J Oncol Pharm Pract. 2016 Feb;22(1):21-5. doi: 10.1177/1078155214546564. Epub 2014 Aug 10.

PMID:
25113309
14.

Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.

Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK.

Head Neck. 2014 Nov;36(11):1662-8. doi: 10.1002/hed.23505. Epub 2014 Aug 28. Review.

PMID:
24115154
15.

Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!

Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK.

Adv Anat Pathol. 2013 Nov;20(6):416-23. doi: 10.1097/PAP.0b013e3182a92df1. Review.

PMID:
24113312
16.

Multimodal snapshot spectral imaging for oral cancer diagnostics: a pilot study.

Bedard N, Schwarz RA, Hu A, Bhattar V, Howe J, Williams MD, Gillenwater AM, Richards-Kortum R, Tkaczyk TS.

Biomed Opt Express. 2013 May 24;4(6):938-49. doi: 10.1364/BOE.4.000938. Print 2013 Jun 1.

17.

Primary intestinal-like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype.

Gillenwater AM, Frank SJ, Fatani H, El-Naggar AK.

Head Neck. 2013 Aug;35(8):E234-6. doi: 10.1002/hed.23059. Epub 2012 Oct 29.

PMID:
23108630
18.

Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.

Rosbach KJ, Williams MD, Gillenwater AM, Richards-Kortum RR.

Transl Oncol. 2012 Jun;5(3):160-71. Epub 2012 Jun 1.

19.

Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia.

Pierce MC, Schwarz RA, Bhattar VS, Mondrik S, Williams MD, Lee JJ, Richards-Kortum R, Gillenwater AM.

Cancer Prev Res (Phila). 2012 Jun;5(6):801-9. doi: 10.1158/1940-6207.CAPR-11-0555. Epub 2012 May 2.

20.

Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer.

Vila PM, Park CW, Pierce MC, Goldstein GH, Levy L, Gurudutt VV, Polydorides AD, Godbold JH, Teng MS, Genden EM, Miles BA, Anandasabapathy S, Gillenwater AM, Richards-Kortum R, Sikora AG.

Ann Surg Oncol. 2012 Oct;19(11):3534-9. doi: 10.1245/s10434-012-2351-1. Epub 2012 Apr 11.

21.

High-Resolution Optical Imaging of Benign and Malignant Mucosa in the Upper Aerodigestive Tract: An Atlas for Image-Guided Surgery.

Levy LL, Vila PM, Park RW, Schwarz R, Polydorides AD, Teng MS, Gurudutt VV, Genden EM, Miles B, Anandasabapathy S, Gillenwater AM, Richards-Kortum R, Sikora AG.

ISRN Minim Invasive Surg. 2012;2012. pii: 364285.

22.

Noninvasive imaging of oral neoplasia with a high-resolution fiber-optic microendoscope.

Muldoon TJ, Roblyer D, Williams MD, Stepanek VM, Richards-Kortum R, Gillenwater AM.

Head Neck. 2012 Mar;34(3):305-12. doi: 10.1002/hed.21735. Epub 2011 Mar 16.

23.

Prospective evaluation of a portable depth-sensitive optical spectroscopy device to identify oral neoplasia.

Schwarz RA, Gao W, Stepanek VM, Le TT, Bhattar VS, Williams MD, Wu JK, Vigneswaran N, Adler-Storthz K, Gillenwater AM, Richards-Kortum R.

Biomed Opt Express. 2010 Dec 8;2(1):89-99. doi: 10.1364/BOE.2.000089.

24.

Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasia.

Roblyer D, Kurachi C, Stepanek V, Schwarz RA, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R.

J Biomed Opt. 2010 Nov-Dec;15(6):066017. doi: 10.1117/1.3516593.

25.

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS.

Ann Intern Med. 2010 Sep 21;153(6):358-67. doi: 10.7326/0003-4819-153-6-201009210-00003.

PMID:
20855800
26.

A fiber-optic fluorescence microscope using a consumer-grade digital camera for in vivo cellular imaging.

Shin D, Pierce MC, Gillenwater AM, Williams MD, Richards-Kortum RR.

PLoS One. 2010 Jun 23;5(6):e11218. doi: 10.1371/journal.pone.0011218.

27.

Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics.

Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman SM, Hong WK, Wei Q.

Clin Cancer Res. 2010 Jan 15;16(2):764-74. doi: 10.1158/1078-0432.CCR-09-2156. Epub 2010 Jan 12.

28.

Ecthyma gangrenosum: an unusual cutaneous manifestation of the head and neck.

Funk E, Ivan D, Gillenwater AM.

Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):818-20. doi: 10.1001/archoto.2009.93.

PMID:
19687405
29.

Multidimensional analysis of body image concerns among newly diagnosed patients with oral cavity cancer.

Fingeret MC, Vidrine DJ, Reece GP, Gillenwater AM, Gritz ER.

Head Neck. 2010 Mar;32(3):301-9. doi: 10.1002/hed.21181.

30.

Objective detection and delineation of oral neoplasia using autofluorescence imaging.

Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R.

Cancer Prev Res (Phila). 2009 May;2(5):423-31. doi: 10.1158/1940-6207.CAPR-08-0229. Epub 2009 Apr 28.

31.

Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.

Holsinger FC, Kies MS, Diaz EM Jr, Gillenwater AM, Lewin JS, Ginsberg LE, Glisson BS, Garden AS, Ark N, Lin HY, Lee JJ, El-Naggar AK, Ki Hong W, Shin DM, Khuri FR.

J Clin Oncol. 2009 Apr 20;27(12):1976-82. doi: 10.1200/JCO.2008.17.6396. Epub 2009 Mar 16.

32.

Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties.

Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R.

J Biomed Opt. 2009 Jan-Feb;14(1):014009. doi: 10.1117/1.3065544.

33.

Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy.

Schwarz RA, Gao W, Redden Weber C, Kurachi C, Lee JJ, El-Naggar AK, Richards-Kortum R, Gillenwater AM.

Cancer. 2009 Apr 15;115(8):1669-79. doi: 10.1002/cncr.24177.

34.

Low-cost, multimodal, portable screening system for early detection of oral cancer.

Rahman M, Chaturvedi P, Gillenwater AM, Richards-Kortum R.

J Biomed Opt. 2008 May-Jun;13(3):030502. doi: 10.1117/1.2907455.

PMID:
18601519
35.

Multispectral optical imaging device for in vivo detection of oral neoplasia.

Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, Gillenwater AM.

J Biomed Opt. 2008 Mar-Apr;13(2):024019. doi: 10.1117/1.2904658.

36.

In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope.

Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortum RR.

Oral Oncol. 2008 Nov;44(11):1059-66. doi: 10.1016/j.oraloncology.2008.02.002. Epub 2008 Apr 8.

37.

Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe.

Schwarz RA, Gao W, Daye D, Williams MD, Richards-Kortum R, Gillenwater AM.

Appl Opt. 2008 Feb 20;47(6):825-34.

39.

Concurrent epithelioid malignant peripheral nerve sheath tumor and papillary thyroid carcinoma in the treated field of Hodgkin's disease.

Yildirim G, Gillenwater AM, Ordonez NG, Garden AS, El-Naggar AK.

Head Neck. 2008 May;30(5):675-9.

PMID:
17972308
40.
41.

Nasal septal abscess in patients with immunosuppression.

Debnam JM, Gillenwater AM, Ginsberg LE.

AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1878-9. Epub 2007 Sep 28.

42.

Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia.

Carlson AL, Gillenwater AM, Williams MD, El-Naggar AK, Richards-Kortum RR.

Technol Cancer Res Treat. 2007 Oct;6(5):361-74.

43.

Gastric aspiration in patients with a laryngectomy stoma: is it possible?

Truong AT, Truong DT, Gillenwater AM, Rozner MA.

J Clin Anesth. 2006 Nov;18(7):557-8. No abstract available.

PMID:
17126793
44.

Rosai-Dorfman disease misdiagnosed as active tuberculosis.

Safdar A, Gillenwater AM, Jones DM, Jorgensen JL, Romaguera JE.

Leuk Lymphoma. 2006 Jul;47(7):1441-2. No abstract available.

PMID:
16923590
45.

Diagnosis of premalignant lesions and early cancers of the oral cavity.

Gillenwater AM, Chambers MS.

Tex Dent J. 2006 Jun;123(6):512-20. No abstract available.

PMID:
16875018
46.

Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent.

Hsu ER, Gillenwater AM, Hasan MQ, Williams MD, El-Naggar AK, Richards-Kortum RR.

Int J Cancer. 2006 Jun 15;118(12):3062-71.

47.

Functional outcomes after laryngopharyngectomy with anterolateral thigh flap reconstruction.

Lewin JS, Barringer DA, May AH, Gillenwater AM, Arnold KA, Roberts DB, Yu P.

Head Neck. 2006 Feb;28(2):142-9.

PMID:
16302192
48.
49.

Functional outcomes after circumferential pharyngoesophageal reconstruction.

Lewin JS, Barringer DA, May AH, Gillenwater AM, Arnold KA, Roberts DB, Yu P.

Laryngoscope. 2005 Jul;115(7):1266-71.

PMID:
15995519
50.

Ball lens coupled fiber-optic probe for depth-resolved spectroscopy of epithelial tissue.

Schwarz RA, Arifler D, Chang SK, Pavlova I, Hussain IA, Mack V, Knight B, Richards-Kortum R, Gillenwater AM.

Opt Lett. 2005 May 15;30(10):1159-61.

Supplemental Content

Loading ...
Support Center